OUR CAPABILITIES 

Due to the work of Professor Keith Chappell and his research group, the AIBN has the knowledge and infrastructure to ensure Australia can...

Queensland will be a major international hub for vaccine discovery and development with a $32 million partnership secured between The...

The National Biologics Facility is excited to be working with Dr Adam Wheatly and team from the Doherty Institute to deliver new...

Researchers at the Doherty Institute, with collaborators from The University of Queensland’s National Biologics Facility and industry...

The University of Queensland is set to take a second-generation molecular clamp vaccine to a proof-of-concept human trial. Dr Melanie...